Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008. Int J Cancer. 2010, 127: 2893-2917.
Article
CAS
PubMed
Google Scholar
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90.
Article
PubMed
Google Scholar
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kumme JA, Shah KV, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19.
Article
CAS
PubMed
Google Scholar
Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, et al: Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004, 78: 11451-11460.
Article
PubMed
PubMed Central
Google Scholar
Beaudenon S, Huibregtse JM: HPV E6, E6AP and cervical cancer. BMC Biochem. 2008, 9 (1): S4-
Article
PubMed
PubMed Central
Google Scholar
Magnusson PK, Sparen P, Gyllensten UB: Genetic link to cervical tumours. Nature. 1999, 400: 29-30.
Article
CAS
PubMed
Google Scholar
Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM: HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet. 1994, 6: 157-162.
Article
CAS
PubMed
Google Scholar
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993, 75: 805-816.
Article
CAS
PubMed
Google Scholar
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al: WAF1, a potential mediator of p53 tumor suppression. Cell. 1993, 75: 817-825.
Article
CAS
PubMed
Google Scholar
Gartel AL, Serfas MS, Tyner AL: p21–negative regulator of the cell cycle. Proc Soc Exp Biol Med. 1996, 213: 138-149.
Article
CAS
PubMed
Google Scholar
Harada K, Ogden GR: An overview of the cell cycle arrest protein, p21(WAF1). Oral Oncol. 2000, 36: 3-7.
Article
CAS
PubMed
Google Scholar
Jung YS, Qian Y, Chen X: Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal. 2010, 22: 1003-1012.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abbas T, Dutta A: p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009, 9: 400-414.
Article
CAS
PubMed
PubMed Central
Google Scholar
Santiago-Raber ML, Lawson BR, Dummer W, Barnhouse M, Koundouris S, Wilson CB, et al: Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol. 2001, 167: 4067-4074.
Article
CAS
PubMed
Google Scholar
Prives C, Gottifredi V: The p21 and PCNA partnership: a new twist for an old plot. Cell Cycle. 2008, 7: 3840-3846.
Article
CAS
PubMed
Google Scholar
Santos AM, Sousa H, Pinto D, Portela C, Pereira D, Catarino R, et al: Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer. Eur J Cancer. 2006, 42: 958-963.
Article
CAS
PubMed
Google Scholar
Roh J, Kim M, Kim J, Park N, Song Y, Kang S, et al: Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Lett. 2001, 165: 59-62.
Article
CAS
PubMed
Google Scholar
Chedid M, Michieli P, Lengel C, Huppi K, Givol D: A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene. 1994, 9: 3021-3024.
CAS
PubMed
Google Scholar
Harima Y, Sawada S, Nagata K, Sougawa M, Ostapenko V, Ohnishi T: Polymorphism of the WAF1 gene is related to susceptibility to cervical cancer in Japanese women. Int J Mol Med. 2001, 7: 261-264.
CAS
PubMed
Google Scholar
Bhattacharya P, Sengupta S: Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Gynecol Oncol. 205, 99: 176-182.
Article
Google Scholar
Liu X, Zhang S, Ruan Q, Ji Y, Ma L, Zhang Y: Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning Province, China. Int J Gynecol Cancer. 2010, 20: 147-153.
Article
PubMed
Google Scholar
Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001, 68: 978-989.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee JE, Lee SJ, Namkoong SE, Um SJ, Sull JW, Jee SH, et al: Gene-gene and gene-environmental interactions of p53, p21, and IRF-1 polymorphisms in Korean women with cervix cancer. Int J Gynecol Cancer. 2004, 14: 118-125.
Article
CAS
PubMed
Google Scholar
Jiang P, Liu J, Li W, Zeng X, Tang J: Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women. Acta Biochim Biophys Sin (Shanghai). 2010, 42: 671-676.
Article
CAS
Google Scholar
Tian Q, Lu W, Chen H, Ye F, Xie X: The nonsynonymous single-nucleotide polymorphisms in codon 31 of p21 gene and the susceptibility to cervical cancer in Chinese women. Int J Gynecol Cancer. 2009, 19: 1011-1014.
Article
PubMed
Google Scholar
Roh JW, Kim BK, Lee CH, Kim J, Chung HH, Kim JW, et al: P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women. Oncol Res. 2010, 18: 453-459.
Article
PubMed
Google Scholar
Facher EA, Becich MJ, Deka A, Law JC: Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene. Cancer. 1997, 79: 2424-2429.
Article
CAS
PubMed
Google Scholar
Werness BA, Wang HQ, Chance J, Goldstein DJ: p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix. Mod Pathol. 1997, 10: 578-584.
CAS
PubMed
Google Scholar
Milde-Langosch K, Riethdorf S, Kraus-Poppinghaus A, Riethdorf L, Loning T: Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch. 2001, 439: 55-61.
Article
CAS
PubMed
Google Scholar
Graflund M, Sorbe B, Karlsson M: Immunohistochemical expression of p53, bcl-2, and p21(WAF1/CIP1) in early cervical carcinoma: correlation with clinical outcome. Int J Gynecol Cancer. 2002, 12: 290-298.
Article
PubMed
Google Scholar